wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33522784-067FCB21-D16E-4937-A5C7-FAE5D7FE2BB7
Q33522784-067FCB21-D16E-4937-A5C7-FAE5D7FE2BB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33522784-067FCB21-D16E-4937-A5C7-FAE5D7FE2BB7
Time to full publication of studies of anticancer drugs for breast cancer, and the potential for publication bias.
P2860
Q33522784-067FCB21-D16E-4937-A5C7-FAE5D7FE2BB7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33522784-067FCB21-D16E-4937-A5C7-FAE5D7FE2BB7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b00368b31a7bb05e625edae14ffdea900517d8a3
P2860
Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysis.